Back to results
US 9,868,950 B2Granted
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
AssigneeAlnylam Pharmaceuticals, Inc.
InventorsAntonin de Fougerolles, Tatiana Novobrantseva, Gregory Hinkle
Life of this patent
Estimating the term…
Abstract
The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a Serum Amyloid A (SAA) gene, and methods of using the dsRNA to inhibit expression of SAA.
Claims21
A double-stranded ribonucleic acid (dsRNA), wherein said dsRNA comprises a sense strand 15-30 nucleotides in length and an antisense strand 15-30 nucleotides in length, the antisense strand comprising a region of complementarity which is complementary to at least 15 nucleotides of SEQ ID NO:179.
Dependencies are inferred from the claim text.